Jolt Health Inc. operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada. It focuses on sexual health, with or without the benefit of CBD, acquired pursuant to various licenses. The company also offers CannaStrip, an oral muco-adhesive strips enhance the bioavailability of hemp oil extracts and THC, increasing the impact and duration of the health benefits; Arousel Gel, a topical gel infused with CBD and/or THC that increases genital blood flow causing vaginal engorgement/lubrication and clitoral engorgement/sensitivity; and CannaMint, a patent-protected technology that uses orally dissolvable mints to deliver CBD or THC for various conditions. In addition, it provides female sexual dysfunction supplement, a female sexual desire supplement; ToConceive, a vaginal moisturize; and male enhancement gel with CBD, a topical personal care penile gel. The company was formerly known as Love Pharma Inc. and changed its name to Jolt Health Inc. in May 2023. Jolt Health Inc. is headquartered in Vancouver, Canada.
Часто задаваемые вопросы
В каком секторе работает Jolt Health Inc. (formerly was LUV/Love Pharma Inc. until 2023-05-25) (JOLT)?
Jolt Health Inc. (formerly was LUV/Love Pharma Inc. until 2023-05-25) относится к сектору Прочее.
Какова текущая цена акций Jolt Health Inc. (formerly was LUV/Love Pharma Inc. until 2023-05-25) (JOLT)?
По последним данным, цена акций Jolt Health Inc. (formerly was LUV/Love Pharma Inc. until 2023-05-25) составляет 0,04 CA$, предыдущее закрытие — 0,04 CA$.
Выплачивает ли Jolt Health Inc. (formerly was LUV/Love Pharma Inc. until 2023-05-25) (JOLT) дивиденды?
Нет, Jolt Health Inc. (formerly was LUV/Love Pharma Inc. until 2023-05-25) не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Jolt Health Inc. (formerly was LUV/Love Pharma Inc. until 2023-05-25) (JOLT)?
У компании Jolt Health Inc. (formerly was LUV/Love Pharma Inc. until 2023-05-25) бета 1.970, что указывает на повышенную волатильность по сравнению с рынком.